• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南解读:血运重建五十年:我们身处何方,又将走向何处?

Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading?

作者信息

Costa Francesco, Ariotti Sara, Valgimigli Marco, Kolh Philippe, Windecker Stephan

机构信息

Thoraxcenter, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands.

出版信息

J Cardiovasc Transl Res. 2015 Jun;8(4):211-20. doi: 10.1007/s12265-015-9632-6. Epub 2015 May 19.

DOI:10.1007/s12265-015-9632-6
PMID:25986910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4473080/
Abstract

The joint European Society of Cardiology and European Association of Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization collect and summarize the evidence regarding decision-making, diagnostics, and therapeutics in various clinical scenarios of coronary artery disease, including elective, urgent, and emergency settings. The 2014 document updates and extends the effort started in 2010, year of the first edition of these guidelines. Importantly, this latest edition provides a systematic review of all randomized clinical trials performed since 1980, comparing different strategies of myocardial revascularization, including coronary artery bypass graft (CABG), balloon angioplasty, percutaneous coronary intervention (PCI) with bare-metal stents (BMS) and first- and second-generation drug-eluting stents (DES). This review aims to highlight the most relevant novelties introduced by the 2014 edition of the ESC/EACTS myocardial revascularization guidelines as compared with the previous edition and to describe similarities and differences with the American societies' guidelines.

摘要

欧洲心脏病学会和欧洲心胸外科学会(ESC/EACTS)联合发布的心肌血运重建指南收集并总结了冠状动脉疾病各种临床场景中有关决策、诊断和治疗的证据,包括择期、紧急和急诊情况。2014年的这份文件更新并扩展了始于2010年(即这些指南第一版发布之年)的工作。重要的是,最新版对自1980年以来进行的所有比较不同心肌血运重建策略的随机临床试验进行了系统回顾,这些策略包括冠状动脉旁路移植术(CABG)、球囊血管成形术、使用裸金属支架(BMS)以及第一代和第二代药物洗脱支架(DES)的经皮冠状动脉介入治疗(PCI)。本综述旨在突出ESC/EACTS 2014年版心肌血运重建指南相较于上一版引入的最相关新内容,并描述与美国学会指南的异同。

相似文献

1
Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading?2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南解读:血运重建五十年:我们身处何方,又将走向何处?
J Cardiovasc Transl Res. 2015 Jun;8(4):211-20. doi: 10.1007/s12265-015-9632-6. Epub 2015 May 19.
2
Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.左主干冠状动脉狭窄:药物洗脱支架与冠状动脉旁路移植术的荟萃分析。
JACC Cardiovasc Interv. 2013 Dec;6(12):1219-30. doi: 10.1016/j.jcin.2013.07.008.
3
Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies.糖尿病合并左主干和/或多支血管病变患者搭桥手术与药物洗脱支架置入术的比较:一项对随机和非随机研究的系统评价与荟萃分析
Cardiol J. 2015;22(2):123-34. doi: 10.5603/CJ.a2014.0036. Epub 2014 May 20.
4
Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data.药物洗脱支架经皮冠状动脉介入治疗与旁路手术治疗糖尿病多支血管病变的效果比较:随机临床试验数据的综合系统评价和荟萃分析。
J Am Heart Assoc. 2013 Aug 7;2(4):e000354. doi: 10.1161/JAHA.113.000354.
5
Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials.胰岛素治疗的2型糖尿病患者冠状动脉搭桥手术与经皮冠状动脉介入治疗的比较:6项随机对照试验的系统评价和荟萃分析
Cardiovasc Diabetol. 2016 Jan 6;15:2. doi: 10.1186/s12933-015-0323-z.
6
Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis.经皮介入治疗与冠状动脉旁路移植术治疗左主干冠状动脉狭窄:一项系统评价和荟萃分析。
BMC Med. 2017 Apr 21;15(1):84. doi: 10.1186/s12916-017-0853-1.
7
Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease.贝叶斯方法肯定了经皮冠状动脉介入治疗在改善无保护左主干冠状动脉疾病患者生存方面的应用。
Circulation. 2013 Jun 4;127(22):2177-85. doi: 10.1161/CIRCULATIONAHA.112.000646. Epub 2013 May 14.
8
Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials.在多支血管病变中,冠状动脉搭桥手术优于药物洗脱支架。当代随机对照试验的系统评价和荟萃分析。
Int J Cardiol. 2016 May 1;210:19-24. doi: 10.1016/j.ijcard.2016.02.090. Epub 2016 Feb 18.
9
Coronary artery stents: a rapid systematic review and economic evaluation.冠状动脉支架:一项快速系统评价与经济学评估
Health Technol Assess. 2004 Sep;8(35):iii-iv, 1-242. doi: 10.3310/hta8350.
10
A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.药物洗脱支架时代经皮冠状动脉介入治疗与手术治疗多支血管病变的成本效果系统评价。
Eur Heart J Qual Care Clin Outcomes. 2016 Oct 1;2(4):261-270. doi: 10.1093/ehjqcco/qcw007.

引用本文的文献

1
Current indications for the intrathoracic transposition of the omentum.目前大网膜胸腔内转位术的适应证。
J Cardiothorac Surg. 2019 Jun 10;14(1):103. doi: 10.1186/s13019-019-0924-9.
2
The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short.冠状动脉支架植入术后双联抗血小板治疗的最佳持续时间:过犹不及。
Cardiovasc Diagn Ther. 2018 Oct;8(5):630-646. doi: 10.21037/cdt.2018.10.01.
3
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies.双联抗血小板治疗持续时间:协调不一致之处。
Drugs. 2017 Oct;77(16):1733-1754. doi: 10.1007/s40265-017-0806-1.
4
Current trends in selection of conduits for coronary artery bypass grafting.冠状动脉旁路移植术中血管移植物选择的当前趋势
Gen Thorac Cardiovasc Surg. 2017 Oct;65(10):549-556. doi: 10.1007/s11748-017-0807-8. Epub 2017 Aug 9.
5
Evaluation of safety and efficacy of elective PCI in patients with cardiac insufficiency.心功能不全患者择期经皮冠状动脉介入治疗的安全性和有效性评估。
Exp Ther Med. 2017 Feb;13(2):609-613. doi: 10.3892/etm.2016.4005. Epub 2016 Dec 27.
6
The role of coronary artery bypass grafting in patients with ischemic cardiomyopathy in the current era.当代缺血性心肌病患者冠状动脉旁路移植术的作用。
J Thorac Dis. 2016 Sep;8(9):E1032-E1033. doi: 10.21037/jtd.2016.08.37.

本文引用的文献

1
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction.替格瑞洛在既往心肌梗死患者中的长期应用
N Engl J Med. 2015 Sep 24;373(13):1274-5. doi: 10.1056/NEJMc1508692.
2
Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.经皮冠状动脉介入治疗后急性肾损伤:AKI-MATRIX(通过桡动脉穿刺部位及血管造影X系统全面应用减少急性肾损伤不良出血事件)子研究的原理
Catheter Cardiovasc Interv. 2015 Nov;86(5):950-7. doi: 10.1002/ccd.25932. Epub 2015 Apr 9.
3
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.经皮冠状动脉介入治疗的急性冠状动脉综合征患者中桡动脉与股动脉入路的随机多中心试验。
Lancet. 2015 Jun 20;385(9986):2465-76. doi: 10.1016/S0140-6736(15)60292-6. Epub 2015 Mar 16.
4
Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing intraprocedural versus post-stenting prolonged bivalirudin infusion. Rationale and design of the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT substudy.光学相干断层扫描评估ST段抬高型心肌梗死患者在术中与支架置入后延长比伐卢定输注时的残余血栓负荷。MATRIX(经桡动脉入路和血管造影X线技术最小化不良出血事件)OCT子研究的原理与设计。
EuroIntervention. 2015 Mar;10(11):1311-7. doi: 10.4244/EIJY15M02_10.
5
Efficacy of a device to narrow the coronary sinus in refractory angina.一种用于缩窄冠状静脉窦治疗难治性心绞痛的装置的疗效。
N Engl J Med. 2015 Feb 5;372(6):519-27. doi: 10.1056/NEJMoa1402556.
6
Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program.经桡动脉穿刺部位及血管造影X程序系统实施以减少不良出血事件的设计与原理
Am Heart J. 2014 Dec;168(6):838-45.e6. doi: 10.1016/j.ahj.2014.08.013. Epub 2014 Sep 16.
7
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.药物洗脱支架置入术后12个月或30个月的双联抗血小板治疗。
N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16.
8
Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis.钴铬依维莫司洗脱支架或裸金属支架对致命和非致命心血管事件的影响:患者水平的荟萃分析。
BMJ. 2014 Nov 4;349:g6427. doi: 10.1136/bmj.g6427.
9
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南:执行摘要:美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Dec 23;130(25):2354-94. doi: 10.1161/CIR.0000000000000133. Epub 2014 Sep 23.
10
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组编写,欧洲经皮心血管介入协会(EAPCI)提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.